Article
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy.
Digestive diseases (Basel, Switzerland) - 1 Jan 2012
Ueda Taisuke, Tsuchiya Kaoru, Hashimoto Satoru, Inoue Taisuke, Enomoto Nobuyuki, Inao Mie, Tanaka Atsushi, Kaito Masahiko, Imazeki Fumio, Nishiguchi Shuhei, Mochida Satoshi, Yokosuka Osamu, Yatsuhashi Hiroshi, Izumi Namiki, Kudo Masatoshi
Abstract excerpt
BACKGROUND/AIMS: Peginterferon (PEG-IFN) + ribavirin (RBV) combination therapy is the current standard of care for chronic hepatitis C. However, more than half of the patients cannot achieve sustained viral response (SVR). In Japan, the clinical benefit of retreatment with PEG-IFN + RBV combination retreatment is still unknown. METHODS: We collected clinical data in 106 chronic hepatitis C patients who failed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.